FutureAdvisor’s Biogen BIIB Stock Holding History

FutureAdvisor’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,593	Closed	-$328K	–	58
2014 Q4	$328K	Buy	+6,593	New	+$2.13M	0.11%	44

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

FutureAdvisor's BIIB Position: Q1 2015 in Review

FutureAdvisor sold out of Biogen (BIIB) in Q1 2015, closing a stake of 6,593 shares — an estimated $328K sold.

FutureAdvisor first reported a position in BIIB in Q4 2014 and held it in 1 quarter. The position peaked at $328K in Q4 2014. 966 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

FutureAdvisor reported no remaining Biogen position as of Q1 2015 after selling out during the quarter.
FutureAdvisor sold 6,593 Biogen shares in Q1 2015, an estimated $328K.
FutureAdvisor first reported a position in Biogen in Q4 2014 and held it in 1 quarter.
FutureAdvisor's Biogen position peaked at $328K in Q4 2014.
966 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on FutureAdvisor's 13F filing for Q1 2015, filed 15 May 2015.